JamesVincentFioricaMD
Obstetrics & Gynecology • Sarasota, FLGynecologic Oncology
Clinical Professor of Obstetrics & Gynecology, Florida State College of Medicine
Dr. Fiorica is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1888 Hillview St
Sarasota, FL 34239Phone+1 941-917-8383Fax+1 941-917-8930
Summary
- Dr. James Fiorica is a gynecologic oncologist based in Sarasota, FL, with a specialty in obstetrics and gynecology. He serves as the Vice President and Chief Medical Officer at Sarasota Memorial Hospital and is a Clinical Professor at Florida State University College of Medicine. His education includes a fellowship in hematology and medical oncology, a residency in obstetrics and gynecology, and a post-doctoral fellowship at Brown University. He has expertise in fallopian tube carcinoma, hysterectomy, ovarian cysts, and cervical cancer. Dr. Fiorica has contributed to several significant publications and clinical trials, specifically focusing on gynecologic cancers. He has received multiple accolades, including being named in "Top Doctors" lists by Castle Connolly and other publications.
Education & Training
Brown UniversityPost-Doctoral Fellowship, 1990
University of South Florida MorsaniFellowship, Hematology and Medical Oncology, 1987 - 1989- University of South Florida MorsaniResidency, Obstetrics and Gynecology, 1982 - 1986
Tufts University School of MedicineClass of 1982
Certifications & Licensure
FL State Medical License 1983 - 2026
MA State Medical License 1987 - 2015
NY State Medical License 1985 - 1994
American Board of Obstetrics and Gynecology Obstetrics & Gynecology- American Board of Obstetrics and Gynecology Gynecologic Oncology
Awards, Honors, & Recognition
- Sarasota Magazine: Top Doctors Castle Connolly, 2006-2017
- America's Top Doctors Castle Connolly, 2002-2014
- America's Top Doctors for Cancer Castle Connolly, 2005-2013
- Join now to see all
Clinical Trials
- Topotecan in Treating Women With Persistent or Recurrent Cervical Cancer Start of enrollment: 2005 Feb 01
- Radiation Therapy With or Without Cisplatin in Treating Patients With Recurrent Endometrial Cancer Start of enrollment: 2008 Feb 25
- Diet and Physical Activity Change or Usual Care in Improving Progression-Free Survival in Patients With Previously Treated Stage II, III, or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Start of enrollment: 2012 Jun 18
- Join now to see all
Publications & Presentations
PubMed
- 38 citationsA randomized, double-blind, placebo-controlled phase 1b/2 study of ralimetinib, a p38 MAPK inhibitor, plus gemcitabine and carboplatin versus gemcitabine and carboplat...Ignace Vergote, Florian Heitz, Paul Buderath, Matthew Powell, Jalid Sehouli
Gynecologic Oncology. 2020-01-01 - 72 citationsEvaluation of a Streamlined Oncologist-Led BRCA Mutation Testing and Counseling Model for Patients With Ovarian CancerNicoletta Colombo, Gloria S. Huang, Giovanni Scambia, Eva Chalas, Sandro Pignata
Journal of Clinical Oncology. 2018-03-20 - 55 citationsBreast Cancer Screening, Mammography, and Other Modalities.James Fiorica
Clinical Obstetrics and Gynecology. 2016-12-01
Lectures
- 16th Annual Primary Care update - Session 2Continuing Medical Education Institute, Inc, Marco Island, Florida - 3/25/2013
- 11th Annual Spring Conference on Challenges in Primary Care MedicineSymposia Medicus, Anaheim, California - 4/2/2012
- 17th Annual Challenges in GynecologySymposia Medicus, New York, New York - 12/16/2011
Press Mentions
SMH #1 in World for "Watchman" TreatmentFebruary 6th, 2025- Covid Politics Leave a Florida Public Hospital ShakenMarch 19th, 2023
- Report Finds Sarasota Memorial Hospital COVID-19 Patients Fared Better Than MostFebruary 24th, 2023
- Join now to see all
Research History
- Principal Investigator- Sarasota, NRG Oncology (GOG)Conducting practice-defining, multiinstitutional phase II and III trials sponsored primarily by the National Cancer Institute (NCI)2005 - Present
Professional Memberships
- Fellow
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
